Incysus Advances T-Cell Therapy into Phase 1 Trial for Blood Cancers
News
Incysus and the University of Alabama at Birmingham (UAB) are advancing the company’s investigational gamma-delta (γδ) T-cell therapy into a Phase 1 clinical study for the treatment of leukemia and lymphoma ... Read more